FASEB Journal · Nov 20, 2026
Aerobic Exercise Reduces Pressure‐Overload‐Induced Myocardial Fibrosis via Inhibiting USP22 to Enhance BRD4 Ubiquitination
By Ren F, Zhao M, Zhang Z et al.
Pathological myocardial fibrosis is the core pathological process by which excessive stress induces myocardial remodeling and eventually leads to heart failure. Aerobic exercise, as an effective non‐pharmacological intervention method, can counteract myocardial fibrosis. However, the underlying regulatory mechanism remains unclear. The deubiquitinating enzyme USP22 is widely involved in the pathological processes of various cardiovascular diseases. This study aims to investigate whether aerobic exercise can improve myocardial fibrosis induced by stress overload by regulating the USP22‐BRD4 signaling pathway. A transverse aortic constriction (TAC) mouse model of pressure overload was constructed In vivo, and combined with aerobic exercise intervention and AAV9‐USP22 overexpression intervention. Survival rate analysis, cardiac ultrasound, histopathological staining, and molecular detection results confirmed that pressure overload can induce high expression of USP22 in cardiac fibroblasts. Aerobic exercise can inhibit USP22‐mediated myocardial fibrosis, improve cardiac function, and overexpression of USP22 can counteract the cardiac protective effect brought by exercise. In vitro, primary cardiac fibroblasts were stimulated with TGF‐β, and silencing of USP22 significantly inhibited fibroblast migration, myofibroblast transformation, and the expression of fibrosis markers such as fibronectin, collagen I, collagen III, and α‐SMA. Overexpression of USP22 further amplified the pro‐fibrotic phenotype. At the mechanism level, USP22 interacts with BRD4 at the protein level and increases the stability of BRD4 protein through deubiquitination modification; rescue experiments confirmed that BRD4 is the downstream effector molecule of USP22 in promoting fibrosis. In conclusion, aerobic exercise downregulates USP22 expression, reduces the stability of BRD4 protein, and thereby inhibits the activation of cardiac fibroblasts and myocardial interstitial fibrosis. The USP22‐BRD4 regulatory axis can serve as a potential intervention target for pressure overload‐induced heart failure and provide a new molecular theoretical basis for clinical cardiac rehabilitation exercise programs.